drugset / Trial / NCT04458129

Polyethylene Glycol and Intestinal Inflammation in Cystic Fibrosis

NCT04458129

Phase 2 Terminated 23 enrolled University Hospital, Bordeaux
NaSingle-groupOpen-labelTreatment

Summary

The main objective of the study is to evaluate the effectiveness of polyethylene glycol treatment on intestinal inflammation in children with cystic fibrosis. In this test, a method adapted from the Fleming one-step scheme will be used. The success rate is measured by the proportion of patients with fecal calprotectin levels \< 250 µg/g at 3 months after treatment initiation.

Timeline

Start
2020-09-29
Primary completion
2022-04-08
Completion
2022-07-08

Drugs

EvaluationDrugModalityDoseRoute
Subject polyethylene glycol Other / unclassified 0.7 g/kg Oral

Indications